YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by…
Pre-Market Stock Futures: Futures are trading lower as we prepare to wrap up the summer months and head into the Labor Day long weekend holiday. All the major indices closed lower on Friday, but the markets enjoyed a positive week overall.…
Photo by geralt on Pixabay Moderna's commercial business has shrunk and is lossmaking, which puts the weight of its market value on a pipeline rather than on revenue. Moderna (MRNA) has returned about 486% over the trailing twelve months,…
Photo by geralt on Pixabay Before the melanoma result, the visible signs were an enrolled trial, a partner paying half its cost, and a market that had stopped pricing an unusually large move Moderna (MRNA) stock has multiplied over the pas…
Photo by geralt on Pixabay The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short sellers in the stock took a record single-session loss. Moderna (MRNA) closed Wednesday at $…
Quick Read ATTO trades near $20, already 9% below its IPO print, with the entire pipeline built around blocking IL-31, dubbed the 'itch cytokine.' Founded in 2023 and backed by $256 million raised, Attovia's next Phase 1 trial won't start…
SAN CARLOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet…
(RTTNews) - Today's top biotech gainers include Attovia Therapeutics, which surged following its Nasdaq debut; American Well, after reporting a narrower loss; Perrigo, which swung back to profit; and UroGen Pharma, following strong second-…
SAN CARLOS, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet…
[Wall Street New York stock exchange stock market] alexsl Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. M…
Tranche 2 upsized by $7 millionto provide enhanced financial runway to support Atento's restructuring following substantial interest from existing investors Participation in Tranche 2 reflects incremental support for the Restructuring Supp…
Delisting is contemplated by the previously announced comprehensive financial restructuring plan aimed at optimizing financial and operational efficiency and driving long-term growth. Delisting affects only the shares of Atento S.A. at a h…
Atento enters into a restructuring support agreement with certain key financial stakeholders to obtain support for a comprehensive balance sheet restructuring Atento continues to work with additional financial stakeholders to achieve a con…
Atento agrees to term sheet with certain major financial stakeholders for at least $30 million of new financing in the near term and pathway to restructuring support agreement Term sheet provides for additional $79 million upon implementat…
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Atento S.A. (NYSE:ATTO), it sends a favourable message to the company's shareholders. While we would…
Both companies have signed the renewal and extension of the Master Service Agreement that includes the joint operations of both entities. With the signing of the agreement, Atento consolidates its position as a preferred partner to deliver…
This new round of capital together with the financing announced on February 3, 2023, will provide Atento with additional operating liquidity and financial flexibility to address its near-term financial liabilities. This capital raise is a…
Kyma Capital, MCI affiliate, and other key investors have provided new financing to support Atento Atento engaged Houlihan Lokey as financial advisor to assist with the fundraising Atento continues to work to add additional investors to th…
Kyma Capital, MCI and other key investors have provided new financing to support Atento Atento engaged Houlihan Lokey as financial advisor to assist with the fundraising Atento continues to work to add additional investors to the new finan…
MCI, LC MCI, LC and MCI Capital, LC CEO Anthony Marlowe "We wanted to diversify MCI's balance sheet with investments in one or more global BPOs that we view as value-add opportunities. We see incredible potential upside in Atento, and look…
IOWA CITY, Iowa, Jan. 11, 2023 (GLOBE NEWSWIRE) -- MCI Capital, LC (“MCI”), a wholly owned subsidiary of MCI, LC, announced today the completion and closing of its previously announced cash tender offer to purchase up to 1,525,000 ordinary…
This week we saw the Atento S.A. (NYSE:ATTO) share price climb by 24%. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. Like a ship taking on water, the share price has sunk 90% in that time. The recent bounc…
IOWA CITY, Iowa, Jan. 04, 2023 (GLOBE NEWSWIRE) -- A MCI Capital, LC (“MCI”), subsidiária da MCI, LC, anunciou hoje a extensão da oferta pública de compra de ações anunciada anteriormente de até 1.525.000 ações ordinárias da Atento S.A. (N…
IOWA CITY, Iowa, Jan. 04, 2023 (GLOBE NEWSWIRE) -- MCI Capital, LC («MCI»), filial participada íntegramente por MCI, LC, ha anunciado hoy la ampliación del plazo de su oferta pública de adquisición en efectivo previamente anunciada para ad…
MCI, LC IOWA CITY, Iowa, Jan. 03, 2023 (GLOBE NEWSWIRE) -- MCI Capital, LC (“MCI”), a wholly-owned subsidiary of MCI, LC, announced today that it is extending the offer period for its previously announced cash tender offer to purchase up t…
IOWA CITY, Iowa, Jan. 03, 2023 (GLOBE NEWSWIRE) -- MCI Capital, LC (“MCI”), a wholly-owned subsidiary of MCI, LC, announced today that it is extending the offer period for its previously announced cash tender offer to purchase up to 1,525,…
Atento S.A. (NYSE:ATTO) Q3 2022 Earnings Call Transcript November 16, 2022 Atento S.A. beats earnings expectations. Reported EPS is $0.1, expectations were $-0.17. Operator: Good morning and welcome to Atento's Third Quarter 2022 Results C…
IOWA CITY, Iowa, Dec. 15, 2022 (GLOBE NEWSWIRE) -- A MCI Capital, LC (“MCI”), subsidiária da MCI, LC, anunciou hoje a extensão da oferta pública de compra anunciada anteriormente de até 1.525.000 ações ordinárias da Atento S.A. (NYSE:ATTO)…
IOWA CITY, Iowa, Dec. 15, 2022 (GLOBE NEWSWIRE) -- MCI Capital, LC («MCI»), filial íntegramente participada por MCI, LC, ha anunciado hoy que amplía el periodo de su oferta pública de adquisición en efectivo anunciada anteriormente para la…
MCI, LC IOWA CITY, Iowa, Dec. 15, 2022 (GLOBE NEWSWIRE) -- MCI Capital, LC (“MCI”), a wholly owned subsidiary of MCI, LC, announced today that it is extending the offer period for its previously announced cash tender offer to purchase up t…
IOWA CITY, Iowa, Dec. 15, 2022 (GLOBE NEWSWIRE) -- MCI Capital, LC (“MCI”), a wholly owned subsidiary of MCI, LC, announced today that it is extending the offer period for its previously announced cash tender offer to purchase up to 1,525,…
NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Atento S.A. (NYSE: ATTO, "Atento" or the "Company"), one of the five largest providers worldwide and a leading company in customer relationship services and business process outsourcing (CRM / BPO),…
Atento is improving CX standards with highly trained human talent and AI-powered products. SAN ANTONIO, Nov. 23, 2022 /PRNewswire/ -- Based on its recent analysis of the Brazilian Customer Experience Outsourcing Services Industry, Frost &…
NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Atento S.A. (the "Company") (NYSE: ATTO) confirmed that on November 18, 2022, MCI Capital, LC commenced a tender offer to purchase up to 1,525,000 of the Company's ordinary shares at a price of $5.00…
Atento (NYSE:ATTO) Third Quarter 2022 Results Key Financial Results Revenue: US$346.8m (down 5.9% from 3Q 2021). Net income: US$1.49m (up from US$11.7m loss in 3Q 2021). Profit margin: 0.4% (up from net loss in 3Q 2021). The move to profit…
IOWA CITY, Iowa, Nov. 19, 2022 (GLOBE NEWSWIRE) -- MCI Capital, LC («MCI»), filial íntegramente participada por MCI, LC, ha anunciado hoy el inicio de una oferta pública de adquisición en efectivo de hasta 1.525.000 acciones ordinarias de…